|
|
|
Insider
Information: |
Hsiao Jane Ph D |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
50,158,203 |
|
Indirect Shares
|
33,836,183 |
|
|
Direct
Value |
$48,843,563 |
|
|
Indirect Value
|
$17,192,522 |
|
|
Total
Shares |
83,994,386 |
|
|
Total
Value |
$66,036,085 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-64.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Asensus Surgical Inc |
ASXC |
Director |
2021-07-01 |
336,895 |
2021-07-01 |
96,746 |
Premium* |
|
Protalix Biotherapeutics |
PLX |
Director |
2007-01-31 |
1,134,060 |
|
0 |
Premium* |
|
Opko Health Inc |
OPK |
|
2024-07-24 |
28,499,880 |
2024-07-24 |
5,127,404 |
Premium* |
|
Prolor Biotech Inc |
PBTH |
Director |
2013-08-29 |
0 |
2013-08-29 |
0 |
Premium* |
|
Non Invasive Monitoring Systems ... |
NIMU |
Interim CEO, Director,... |
2018-12-21 |
16,752,074 |
2018-12-21 |
20,883,660 |
Premium* |
|
Sorrento Therapeutics Inc |
SRNE |
Director |
|
0 |
2010-01-25 |
2,231,719 |
Premium* |
|
Cocrystal Pharma |
COCP |
|
2016-03-15 |
3,435,294 |
2016-03-15 |
5,496,654 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
94 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2014-01-31 |
4 |
B |
$7.96 |
$79,600 |
D/D |
10,000 |
24,465,147 |
2.81 |
- |
|
COCP |
Cocrystal Pharma |
Director |
|
2014-03-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,545,993 |
|
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2014-04-15 |
4 |
B |
$8.03 |
$80,300 |
D/D |
10,000 |
21,338,212 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2014-08-01 |
4 |
OE |
$0.66 |
$1,485,533 |
D/D |
309,583 |
21,647,795 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2014-09-24 |
4 |
OE |
$2.48 |
$500,000 |
I/I |
201,613 |
4,472,581 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2015-01-31 |
4 |
D |
$11.62 |
$2,300,611 |
I/I |
(195,642) |
20,091,062 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2015-01-31 |
4 |
OE |
$0.00 |
$2,300,550 |
I/I |
4,796,158 |
20,286,704 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2015-01-31 |
4 |
D |
$11.78 |
$2,512,529 |
D/D |
(213,342) |
24,371,033 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2015-01-31 |
4 |
OE |
$0.67 |
$2,512,440 |
D/D |
2,936,580 |
24,584,375 |
0 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2015-03-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,496,654 |
5,496,654 |
0 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2015-03-25 |
4 |
B |
$0.92 |
$2,024,000 |
D/D |
2,200,000 |
2,200,000 |
2.39 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2015-08-06 |
4 |
OE |
$7.07 |
$1,023,899 |
I/I |
144,823 |
4,617,404 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2015-08-07 |
4 |
OE |
$7.61 |
$1,588,500 |
D/D |
200,000 |
24,571,033 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2015-08-25 |
4 |
B |
$10.81 |
$216,325 |
D/D |
20,000 |
24,591,033 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2016-03-08 |
4 |
B |
$10.01 |
$12,012 |
D/D |
1,200 |
24,592,233 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2016-03-09 |
4 |
B |
$9.99 |
$11,988 |
D/D |
1,200 |
24,593,433 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2016-03-10 |
4 |
B |
$9.80 |
$11,787 |
D/D |
1,200 |
24,594,633 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2016-03-11 |
4 |
B |
$10.21 |
$12,252 |
D/D |
1,200 |
24,595,833 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2016-03-14 |
4 |
B |
$10.12 |
$12,143 |
D/D |
1,200 |
24,597,033 |
2.81 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2016-03-15 |
4 |
B |
$0.51 |
$630,000 |
D/D |
1,235,294 |
3,435,294 |
2.39 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2016-03-15 |
4 |
B |
$10.00 |
$12,000 |
D/D |
1,200 |
24,598,233 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2016-03-16 |
4 |
B |
$9.99 |
$11,988 |
D/D |
1,200 |
24,599,433 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2016-03-17 |
4 |
B |
$10.59 |
$12,785 |
D/D |
1,200 |
24,600,633 |
2.81 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2017-01-04 |
4 |
OE |
$7.61 |
$856,125 |
D/D |
112,500 |
24,713,133 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2017-05-10 |
4 |
B |
$6.94 |
$278,705 |
D/D |
40,000 |
24,753,133 |
2.81 |
- |
|
94 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|